Arndt-Gottron scleromyxoedema: successful therapy with intravenous immunoglobulins

被引：26

作者：

Gholam, P. ^{[1
]}

Hartmann, M. ^{[1
]}

Enk, A. ^{[1
]}

机构：

[1] Univ Heidelberg, Dept Dermatol, D-69115 Heidelberg, Germany

来源：

BRITISH JOURNAL OF DERMATOLOGY | 2007年 / 157卷 / 05期

关键词：

dermatoneuro syndrome; hd IVIg; high-dose intravenous immunoglobulin; monoclonal gammopathy; scleromyxoedema;

D O I：

10.1111/j.1365-2133.2007.08169.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：1058 / 1060

页数：4

共 10 条

[1] Successful treatment of scleromyxoedema with high dose intravenous immunoglobulin [J].

Karim, A ;

Lawlor, F ;

Black, MM .

CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2004, 29 (03) :317-318

[2] Scleromyxoedema: treatment of cutaneous and systemic manifestations with high-dose intravenous immunoglobulin [J].

Kulczycki, A ;

Nelson, M ;

Eisen, A ;

Heffernan, M .

BRITISH JOURNAL OF DERMATOLOGY, 2003, 149 (06) :1276-1281

[3] Scleromyxedema: Response to high-dose intravenous immunoglobulin (hdIVIg) [J].

Lister, RK ;

Jolles, S ;

Whittaker, S ;

Black, C ;

Forgacs, I ;

Cramp, M ;

Potter, M ;

Rustin, MHA .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2000, 43 (02) :403-408

[4] Combination oral prednisone and intravenous immunoglobulin in the treatment of scleromyxedema [J].

Majeski, C ;

Taher, M ;

Grewal, P ;

Dytoc, M ;

Lauzon, G .

JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2005, 9 (03) :99-104

[5]

MOUTHON I, 1996, CLIN EXP IMMUNOL, V104, P3

[6]

Righi A, 2002, ANN RHEUM DIS, V61, P59, DOI 10.1136/ard.61.1.59

[7] Fever, convulsions and coma in scleromyxedema: A ''dermato-neuro syndrome'' [J].

River, Y ;

Levy, I ;

Gilead, L ;

Orbach, H ;

Almog, Y .

NEUROLOGY, 1996, 46 (06) :1778-1779

[8]

Topf S, 2007, HAUTARZT, V58, P525, DOI 10.1007/s00105-006-1261-1

[9]

Wetter DA, 2005, MAYO CLIN PROC, V80, P41

[10] Tumorous variant of scleromyxedema. Successful therapy with intravenous immunoglobulins [J].

Wojas-Pelc, A ;

Blaszczyk, M ;

Glinska, M ;

Jablonska, S .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2005, 19 (04) :462-465

← 1 →